Cellectar Biosciences, Inc. (CLRB)
3.01
-0.24
(-7.24%)
USD |
NASDAQ |
Mar 02, 16:00
3.01
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences EPS Diluted (Quarterly) : -1.405 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.444M |
| Total Expenses (Quarterly) | 4.444M |
| Enterprise Value | 3.540M |
| Earnings Yield | -214.9% |
| Normalized Earnings Yield | -378.75 |